A prospective, open and controlled clinical study of traditional Chinese medicine (Astragalus / Panax notoginseng) combined with a new oncolytic vaccine in the treatment of Recurrent or Metastatic Cervical Cancer

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2020
This article has no abstract
Epistemonikos ID: 32d96e9de1d63cafb674f4f38c06c3e61b65cce1
First added on: Apr 07, 2025